Trinity Biotech reported $-9.6M in EBITDA for its fiscal quarter ending in December of 2024.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Bayer EUR 4.45B 2.49B Mar/2026
Bio-Rad Laboratories USD 983.8M 1.36B Dec/2025
EDAP TMS EUR -4.92M 843K Sep/2025
J&J USD 7.19B 2.32B Dec/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
OraSure Technologies USD -17.7M 4.06M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Siemens EUR 3.56B 80M Mar/2026
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Tosoh JPY 39.13B 286M Dec/2024
Trinity Biotech USD -9.6M 7.64M Dec/2024
Veracyte USD 42.8M 488K Mar/2026